Related Experiment Video

Updated: Jun 10, 2025

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.2K

Advances in the Understanding and Treatment of Chronic Chagas Cardiomyopathy

Jordan Llerena-Velastegui1,2, Almendra Lopez-Usina1, Camila Mantilla-Cisneros1

  • 1Medical School, Pontifical Catholic University of Ecuador, Quito, Ecuador.

Cardiology Research
|October 18, 2024
PubMed

Insights

This review updates knowledge on Chronic Chagas cardiomyopathy (CCC), highlighting diagnostic and therapeutic challenges. Further research is crucial for improved patient care and treatment strategies for this complex cardiac condition.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Chronic Chagas cardiomyopathy (CCC) is a significant global health concern, affecting both endemic and non-endemic regions.
  • Global migration patterns increase the prevalence of CCC in non-endemic areas, necessitating updated clinical understanding.
  • The complexity and severity of CCC demand a comprehensive review to guide clinical practice and research.

Purpose of the Study:

  • To consolidate current knowledge on Chronic Chagas cardiomyopathy (CCC).
  • To emphasize diagnostic, therapeutic, and prognostic aspects of CCC for improved management.
  • To identify gaps in research and inform future therapeutic strategies.

Main Methods:

  • An exhaustive review of peer-reviewed articles published between January 2020 and April 2024.
  • Literature search conducted across major medical databases, including PubMed and Scopus.
  • Analysis focused on pathophysiology, patient outcomes, diagnostic challenges, and treatment efficacy.

Main Results:

  • Key aspects of CCC pathophysiology were delineated.
  • Patient outcomes, diagnostic challenges, and treatment efficacy were evaluated.
  • Identified critical gaps in current understanding and therapeutic approaches.

Conclusions:

  • Findings necessitate revised clinical guidelines for CCC management.
  • Emphasizes the urgent need for continued research to enhance therapeutic strategies.
  • Future studies must address identified gaps to advance patient care for CCC.

Keywords:
Chronic Chagas cardiomyopathyDiagnostic challengesPathophysiologyPatient outcomesTreatment efficacy

More Related Videos

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

1.4K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.1K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
2
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
2
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2